From his home in Los Angeles, with a budget of just $20,000 and an arsenal of AI tools, 41-year-old Matthew Gallagher has built one of the fastest-growing startups in digital health. His company, Medvi, is on track to hit nearly $1.8 billion in sales with a core team of just two people, realizing a vision of a lean, AI-powered enterprise that many in the tech world have only theorized about.
Quick Facts
- Initial Investment: $20,000 from the founder.
- Projected 2026 Sales: Approaching $1.8 billion.
- Core Team Size: Two employees (the founder and his brother).
From Zero to a Billion-Dollar Run Rate
Medvi, a digital health platform providing online access to GLP-1 weight-loss medications, launched with explosive momentum. In its first month, it attracted 300 customers, a number that jumped to 1,000 in the second. By the end of its first operational year, 2025, the company had pulled in an astonishing $401 million in sales.
This rapid scaling continued without a traditional hiring spree. Gallagher’s only addition to the team was his younger brother, Elliot. The company’s customer base swelled to 250,000 by the end of 2025, generating $65 million in net profit with a 16.2% margin—significantly higher than the 5.5% margin of publicly listed competitor Hims.
The founder’s personal earnings from the venture are estimated to be between $70 and $80 million. The achievement caught the attention of OpenAI CEO Sam Altman, who two years ago predicted the rise of a “one-person, billion-dollar company” and later expressed a desire to “meet this man.”
The AI-Powered Solopreneur’s Toolkit
Gallagher’s strategy was to use AI for nearly every business function. He leveraged a ready-made virtual medicine platform from CareValidate to connect customers with doctors and pharmacies, then built his entire operational layer on top of it using off-the-shelf AI.
He used a combination of ChatGPT, Claude, and Grok to write code and build the company website. Marketing content, images, and videos were generated with tools from Midjourney and Runway, while the customer service voice was created using ElevenLabs. This AI-first approach allowed him to build the entire company in just two months, bypassing the need for engineering, marketing, and support teams.
The Human Element in an AI World
The hyper-lean model was not without its problems. The AI customer service bot occasionally invented non-existent prices or advertised products Medvi didn’t sell. When frustrated customers demanded to speak to a human, the calls were routed directly to Gallagher’s personal phone—leading him to handle over 1,000 calls himself.
To manage the chaos, he eventually integrated the customer service systems of his virtual medicine partners and outsourced legal, accounting, and advertising work. After insisting on not hiring, he finally brought on his brother Elliot in April to help manage the workload. Despite the company’s massive scale, Gallagher admits to a surprising challenge: “I sometimes think about hiring people just because I feel lonely.”
Why This Matters for MENA’s Tech Scene
While Medvi is a US-based story, it offers a powerful blueprint for founders and VCs across the MENA region. In a market increasingly focused on capital efficiency and sustainable growth, Gallagher’s model demonstrates how AI can drastically lower the barrier to entry for building a high-growth company.
For MENA startups, this AI-first approach could unlock opportunities to compete with larger, more established players without the need for massive early-stage funding rounds. As digital transformation accelerates in hubs like Riyadh, Dubai, and Cairo, founders who can effectively leverage AI to automate operations—from software development to customer acquisition—will have a distinct competitive advantage. Medvi’s success is a clear signal that the era of the lean, hyper-scalable, AI-native startup has arrived, and it’s a model that fits perfectly with the region’s ambitious tech agenda.
About Medvi
Medvi is a digital health platform that provides patients with online access to GLP-1 weight-loss medications. By leveraging a suite of AI tools and a lean operational model, the company aims to offer affordable and convenient access to these treatments without the need for in-person doctor visits.
Source: Albilad Press
